Trial to Evaluate the Impact of Various Pragmatic Interventions to Increase Mammography Uptake Among Defaulted Repeat Screeners in Singapore
REMIND1
Randomized Controlled Trials to Evaluate Outreach Strategies for Increasing Mammogram Uptake in Singaporean Women Who Are Defaulted Repeat Screeners
1 other identifier
interventional
12,750
1 country
1
Brief Summary
Breast cancer is the most common cancer among women in Singapore, accounting for nearly 30% of all female cancers. While regular biennial mammography can reduce mortality, screening rates in Singapore remain low at 34.7%; well below the 70% threshold required for population-level impact. Despite a national screening program in place since 2002, uptake continues to be hindered by psychological, cultural, and logistical barriers. Although various studies have explored different behavioural interventions to boost mammogram uptake; ranging from reminders (traditional mailers, phone calls, text messages) and education to financial incentives, their effectiveness varies by population and context. Furthermore, few large-scale, prospective studies have been conducted locally. Prior research in Singapore is either outdated or limited in scope, and there is a particular lack of rigorous trials evaluating behavioral interventions tailored to women who have defaulted on screening, who faces distinct psychological and behavioral barriers; ranging from low perceived risk and fear, to false reassurance from prior normal results or lack of reminders, or had bad experience (procedural pain or prior false positive results) during last mammogram. Engaging these women is critical, yet challenging, and failure to do so undermines efforts to achieve broad population coverage. The REMIND Study addresses this critical gap by evaluating five pragmatic and scalable outreach strategies to increase mammogram uptake among women who had their last screening more than 2 years ago and are currently overdue. Through a large, randomized controlled trial, the study will generate much-needed local evidence on what works to reengage these women. Findings will directly inform national screening policies and the design of future outreach efforts tailored to Singapore's diverse population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2026
CompletedFirst Submitted
Initial submission to the registry
May 21, 2026
CompletedFirst Posted
Study publicly available on registry
June 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2027
June 16, 2026
April 1, 2026
10 months
May 21, 2026
June 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparison of proportion of participants completing surveillance mammography within 4 months after intervention assignment between interventional arms (2-5) and control arm (Arm 1)
The proportion of women who undergo surveillance mammography within 4 months of receiving the study intervention/reminder will be compared between Arm 1 (control) and Arms 2-5. Mammogram completion will be confirmed through electronic medical records. Results will be reported as the percentage of participants completing mammography in each study arm. Unit of Measure: Percentage of participants (%)
4 months from the time participants receive the intervention/reminder
Secondary Outcomes (3)
Association between participant characteristics and completion of surveillance mammography within 4 months
4 months from the time participants receive the intervention/reminder
Post-trial telephone survey
1-2 months post-trial
Mammogram uptake at 6 and 12 months post-trial
6 and 12 months from the time participants received the first mailed reminder
Study Arms (5)
Control Arm (Arm 1)
NO INTERVENTIONDoes not receive any reminder to go for mammogram
Arm 2: One mailed reminder
EXPERIMENTALReceives a single mail reminder
Arm 3: Two mailed reminders
EXPERIMENTALReceives two mail reminders, 4 weeks apart
Arm 4: Mailed Reminder with Prescheduled Appointment
EXPERIMENTALReceives a mailed reminder with prescheduled appointment
Arm 5: Mailed reminder with enhanced messaging
EXPERIMENTALReceives mailed reminder with enhanced messaging
Interventions
Receives a mailed reminder + follow-up mailed reminder, 4 weeks after the first
Receives one mailed reminder with enhanced messaging motivating recipient to undergo screening
Receives a mailed reminder with basic information about breast cancer and instructions on scheduling a mammogram
Receives one mailed reminder with a pre-scheduled appointment, with instructions to change appointment
Eligibility Criteria
You may qualify if:
- Singaporean citizen
- Age 50-69
- Registered as a patient at the National University Hospital
- Registered and active user of NUHS App
- Signed up with Healthier SG with a primary care provider within the NUHS Primary Care Network
- Must be defaulted repeat screeners : Must have done one prior mammogram screening but not in the past 2 years
You may not qualify if:
- Diagnosis of breast cancer in EPIC
- Mammogram done in the past 24 months in EPIC
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital Singapore
Singapore, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2026
First Posted
June 16, 2026
Study Start
March 9, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2027
Last Updated
June 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share